The presence of at least one of these aberrations in an IDH- and H3-wildtype diffuse glioma is sufficient for a diagnosis of molecular-characterized IDH-wildtype glioblastoma, even in the absence of morphologic evidence of microvascular proliferation and/or necrosis [27]. This evidence concerns the gene IDH1 and glioblastoma.